Onriva Inhalation Capsule 150 mcg (Indacaterol Maleate) is a long-acting bronchodilator designed to help individuals manage chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. Each inhalation capsule contains 150 micrograms of Indacaterol Maleate, a selective long-acting β₂-adrenergic agonist (LABA) that relaxes muscles in the airways, improving airflow and making breathing easier.

Indacaterol Maleate in Onriva offers 24-hour bronchodilation with once-daily dosing, simplifying treatment regimens and supporting better adherence. This product is intended for maintenance treatment and is not suitable for rapid relief of acute bronchospasm. It is delivered via a dry powder inhaler (DPI), ensuring consistent dose delivery and ease of use for patients who require long-term bronchodilation.

রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Key Features and Benefits

Therapeutic Action

• Long-acting bronchodilator: Indacaterol provides sustained airway relaxation for up to 24 hours, helping to reduce breathlessness and improve quality of life in COPD patients.

• Selective β₂-agonist: Targets β₂ receptors in bronchial smooth muscle, minimizing cardiovascular effects compared to non-selective agents.

• Once-daily dosing: Supports patient compliance and adherence to maintenance therapy.

Clinical Benefits

• Improved airflow: Enhances pulmonary function by reducing airway resistance, leading to easier breathing and increased exercise tolerance.

• Symptom control: Helps decrease the frequency and severity of COPD symptoms such as wheezing, coughing, and shortness of breath.

• Reduced exacerbations: Regular use may reduce the risk of COPD flare-ups when combined with appropriate disease management strategies.

Usage and Administration

• Inhalation route: The medication is contained within capsules that are inserted into a compatible dry powder inhaler device. The patient inhales the powdered drug through the mouth.

• Correct technique: Proper inhaler technique is essential to ensure effective delivery of the medication to the lungs. Patients should be instructed on how to use the device correctly and to avoid swallowing the capsule orally.

• Once daily: Taken at the same time each day to maintain consistent therapeutic levels.

  রেজিস্টার্ড চিকিৎসকের পরামর্শ অনুযায়ী ঔষধ সেবন করুন

Safety and Precautions

• Not for acute relief: Onriva should not be used for immediate relief of sudden breathing problems or asthma attacks. A fast-acting rescue inhaler should be available if needed.

• Cardiovascular monitoring: Patients with preexisting heart conditions should be monitored, as LABAs can have cardiovascular effects such as palpitations or changes in blood pressure.

• Hypersensitivity: Avoid use in individuals with known hypersensitivity to indacaterol or any of the product’s excipients.

Indications

Onriva Inhalation Capsule 150 mcg is indicated for the long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema. It is appropriate for adult patients who require sustained bronchodilation and symptom management with a once-daily regimen.

Important Considerations

• Assessment of response: Healthcare providers should regularly assess lung function and COPD symptoms to determine continued appropriateness of therapy.

• Concurrent medications: Use with other long-acting bronchodilators or corticosteroids should be based on clinical judgment and existing treatment guidelines.

• Patient education: Ensuring patients understand their inhalation device technique, dosing schedule, and the difference between maintenance therapy and rescue medication is critical for optimal outcomes.

Packaging and Storage

Onriva Inhalation Capsules are typically supplied in blister packs designed to maintain capsule integrity and protect against moisture. Store in a cool, dry place away from direct sunlight and out of reach of children. Do not use capsules that are damaged or have been exposed to humidity.